GATA3 and gastric cancer: showed that the overexpression of exosomal miR-155-5p derived from PTX-resistant GC cells induces EMT progress and enhances drug resistance in PTX-sensitive GC cells by targeting GATA binding protein 3 (GATA3) and tumor protein p53-inducible nuclear protein 1 (TP53INP1) (103).